Published online November 1, 2007
PEDIATRICS Vol. 120 No. 5 November 2007, pp. e1165-e1173 (doi:10.1542/peds.2007-0037)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, P. J.
Right arrow Articles by Wolter, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, P. J.
Right arrow Articles by Wolter, K. M.
Related Collections
Right arrow Infectious Disease & Immunity

ARTICLE

Effect of Vaccine Shortages on Timeliness of Pneumococcal Conjugate Vaccination: Results From the 2001–2005 National Immunization Survey

Philip J. Smith, PhDa, J. Pekka Nuorti, MD, DSca, James A. Singleton, MSa, Zhen Zhao, PhDa and Kirk M. Wolter, PhDb

a National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
b National Opinion Research Center and University of Chicago, Chicago, Illinois

BACKGROUND. In September 2001 and again in February 2004, the Centers for Disease Control and Prevention announced shortages in the supply of the pneumococcal conjugate vaccine. We describe the effects of the pneumococcal conjugate vaccine shortages in 2001–2003 and 2004 on the timeliness of vaccination uptake for quarterly birth cohorts affected by the shortages.

METHODS. A total of 102478 19- to 35-month-old children were sampled by the National Immunization Survey between 2001 and 2005. Provider-reported vaccination histories were used to evaluate whether children had been administered ≥4 doses of pneumococcal conjugate vaccine by 16 months of age.

RESULTS. Among successive birth cohorts affected by the first shortage, estimated coverage of ≥4 doses of pneumococcal conjugate vaccine by 16 months declined significantly from 28.8% to 18.2%. As the first shortage ended, estimated coverage of ≥4 doses of pneumococcal conjugate vaccine by 16 months increased steadily with each successive birth cohort to 40.2%. From the onset of the second shortage, estimated coverage of ≥4 doses of pneumococcal conjugate vaccine by 16 months declined steadily and significantly to 13.7%. As many as 27% of parents whose child was affected by the first shortage reported that their child's vaccination provider had delayed the administration of pneumococcal conjugate vaccine doses. Of those parents who said that a pneumococcal conjugate vaccine dose was delayed and whose child was not administered ≥4 doses, 2.9% received a reminder notice from the provider to schedule administration of those delayed doses, and 0.2% had an appointment to receive those delayed or missed doses.

CONCLUSIONS. Vaccine shortages can result in delayed or missed doses and can have a dramatic impact on the vaccine coverage of children. Vaccination providers need to communicate effectively with parents so that doses that are delayed or missed during a vaccine shortage are administered when the shortage is resolved.

Key Words: childhood immunization • surveillance and monitoring

Abbreviations: PCV7—pneumococcal conjugate vaccine • ACIP—Advisory Committee on Immunization Practices • CI—confidence interval • CDC—Centers for Disease Control and Prevention • NIS—National Immunization Survey • RDD—random-digit dialing • MSA—metropolitan statistical area

Accepted Apr 17, 2007.